Clinical Trial

Luspatercept in Patients Affected With Rare Inherited Anemias

Name: Luspatercept in Patients Affected With Rare Inherited Anemias — clinical trial record (NCT07331818)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: LUSPARA

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

This is a prospective multicenter phase II basket trial evaluating Luspatercept in patients affected with rare inherited anemias

Trial Details

NCT Number	NCT07331818
Lead Sponsor	EuroBloodNet Association
Conditions	Hereditary Red Blood Cell Disorder (Disorder)
Enrollment	45 participants
Start Date	2026-01-15
Primary Completion	2028-09 (estimated)
Study Completion	2029-09-30 (estimated)
Updated on ClinicalTrials.gov	2026-01-12